1015 related articles for article (PubMed ID: 7699334)
1. A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12.
Skeiky YA; Guderian JA; Benson DR; Bacelar O; Carvalho EM; Kubin M; Badaro R; Trinchieri G; Reed SG
J Exp Med; 1995 Apr; 181(4):1527-37. PubMed ID: 7699334
[TBL] [Abstract][Full Text] [Related]
2. LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile.
Skeiky YA; Kennedy M; Kaufman D; Borges MM; Guderian JA; Scholler JK; Ovendale PJ; Picha KS; Morrissey PJ; Grabstein KH; Campos-Neto A; Reed SG
J Immunol; 1998 Dec; 161(11):6171-9. PubMed ID: 9834103
[TBL] [Abstract][Full Text] [Related]
3. A Leishmania protein that modulates interleukin (IL)-12, IL-10 and tumor necrosis factor-alpha production and expression of B7-1 in human monocyte-derived antigen-presenting cells.
Probst P; Skeiky YA; Steeves M; Gervassi A; Grabstein KH; Reed SG
Eur J Immunol; 1997 Oct; 27(10):2634-42. PubMed ID: 9368620
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of antigens from L. braziliensis isolates from disseminated and cutaneous leishmaniasis on in vitro cytokine production.
Leopoldo PT; Machado PR; Almeida RP; Schriefer A; Giudice A; de Jesus AR; Ho JL; Guimarães LH; Bacellar O; Carvalho EM
BMC Infect Dis; 2006 Apr; 6():75. PubMed ID: 16638143
[TBL] [Abstract][Full Text] [Related]
5. Can interferon-gamma and interleukin-10 balance be associated with severity of human Leishmania (Viannia) braziliensis infection?
Gomes-Silva A; de Cássia Bittar R; Dos Santos Nogueira R; Amato VS; da Silva Mattos M; Oliveira-Neto MP; Coutinho SG; Da-Cruz AM
Clin Exp Immunol; 2007 Sep; 149(3):440-4. PubMed ID: 17614975
[TBL] [Abstract][Full Text] [Related]
6. T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.
Coutinho SG; Oliveira MP; Da-Cruz AM; De Luca PM; Mendonça SC; Bertho AL; Soong L; McMahon-Pratt D
Exp Parasitol; 1996 Nov; 84(2):144-55. PubMed ID: 8932764
[TBL] [Abstract][Full Text] [Related]
7. Effect of LACK and KMP11 on IFN-gamma production by peripheral blood mononuclear cells from cutaneous and mucosal leishmaniasis patients.
Carvalho LP; Passos S; Dutra WO; Soto M; Alonso C; Gollob KJ; Carvalho EM; Ribeiro de Jesus A
Scand J Immunol; 2005 Apr; 61(4):337-42. PubMed ID: 15853916
[TBL] [Abstract][Full Text] [Related]
8. Th1/Th2 immune responses are associated with active cutaneous leishmaniasis and clinical cure is associated with strong interferon-gamma production.
Castellano LR; Filho DC; Argiro L; Dessein H; Prata A; Dessein A; Rodrigues V
Hum Immunol; 2009 Jun; 70(6):383-90. PubMed ID: 19480861
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis.
Bottrel RL; Dutra WO; Martins FA; Gontijo B; Carvalho E; Barral-Netto M; Barral A; Almeida RP; Mayrink W; Locksley R; Gollob KJ
Infect Immun; 2001 May; 69(5):3232-9. PubMed ID: 11292745
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of Th1-type responses in mucosal leishmaniasis patients.
Bacellar O; Lessa H; Schriefer A; Machado P; Ribeiro de Jesus A; Dutra WO; Gollob KJ; Carvalho EM
Infect Immun; 2002 Dec; 70(12):6734-40. PubMed ID: 12438348
[TBL] [Abstract][Full Text] [Related]
11. Testing of four Leishmania vaccine candidates in a mouse model of infection with Leishmania (Viannia) braziliensis, the main causative agent of cutaneous leishmaniasis in the New World.
Salay G; Dorta ML; Santos NM; Mortara RA; Brodskyn C; Oliveira CI; Barbiéri CL; Rodrigues MM
Clin Vaccine Immunol; 2007 Sep; 14(9):1173-81. PubMed ID: 17626159
[TBL] [Abstract][Full Text] [Related]
12. The Leishmania promastigote surface antigen-2 (PSA-2) is specifically recognised by Th1 cells in humans with naturally acquired immunity to L. major.
Kemp M; Handman E; Kemp K; Ismail A; Mustafa MD; Kordofani AY; Bendtzen K; Kharazmi A; Theander TG
FEMS Immunol Med Microbiol; 1998 Mar; 20(3):209-18. PubMed ID: 9566492
[TBL] [Abstract][Full Text] [Related]
13. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection.
O'Sullivan ST; Lederer JA; Horgan AF; Chin DH; Mannick JA; Rodrick ML
Ann Surg; 1995 Oct; 222(4):482-90; discussion 490-2. PubMed ID: 7574928
[TBL] [Abstract][Full Text] [Related]
14. Elongation factor-2, a Th1 stimulatory protein of Leishmania donovani, generates strong IFN-γ and IL-12 response in cured Leishmania-infected patients/hamsters and protects hamsters against Leishmania challenge.
Kushawaha PK; Gupta R; Sundar S; Sahasrabuddhe AA; Dube A
J Immunol; 2011 Dec; 187(12):6417-27. PubMed ID: 22079980
[TBL] [Abstract][Full Text] [Related]
15. Immune responses of leishmaniasis patients to heat shock proteins of Leishmania species and humans.
Skeiky YA; Benson DR; Guderian JA; Whittle JA; Bacelar O; Carvalho EM; Reed SG
Infect Immun; 1995 Oct; 63(10):4105-14. PubMed ID: 7558326
[TBL] [Abstract][Full Text] [Related]
16. IL-15 in human visceral leishmaniasis caused by Leishmania infantum.
Milano S; Di Bella G; D'Agostino P; Barbera C; Caruso R; La Rosa M; Ferlazzo V; Vitale G; La Russa C; Gambino G; Chifari N; Mansueto S; Cillari E
Clin Exp Immunol; 2002 Feb; 127(2):360-5. PubMed ID: 11876762
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 32γ (IL-32γ) is highly expressed in cutaneous and mucosal lesions of American Tegumentary Leishmaniasis patients: association with tumor necrosis factor (TNF) and IL-10.
Galdino H; Maldaner AE; Pessoni LL; Soriani FM; Pereira LI; Pinto SA; Duarte FB; Gomes CM; Fleuri AK; Dorta ML; de Oliveira MA; Teixeira MM; Batista AC; Joosten LA; Vieira LQ; Ribeiro-Dias F
BMC Infect Dis; 2014 May; 14():249. PubMed ID: 24884781
[TBL] [Abstract][Full Text] [Related]
18. Antigen-triggered interferon-γ and interleukin-10 pattern in cured mucosal leishmaniasis patients is shaped during the active phase of disease.
Nogueira RS; Gomes-Silva A; Bittar RC; Silva Mendonça D; Amato VS; da Silva Mattos M; Oliveira-Neto MP; Coutinho SG; Da-Cruz AM
Clin Exp Immunol; 2014 Sep; 177(3):679-86. PubMed ID: 24773586
[TBL] [Abstract][Full Text] [Related]
19. The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of human tegumentary leishmaniasis.
Oliveira WN; Ribeiro LE; Schrieffer A; Machado P; Carvalho EM; Bacellar O
Cytokine; 2014 Apr; 66(2):127-32. PubMed ID: 24485388
[TBL] [Abstract][Full Text] [Related]
20. Comparative Assessment of Induced Immune Responses Following Intramuscular Immunization with Fusion and Cocktail of LeIF, LACK and TSA Genes Against Cutaneous Leishmaniasis in BALB/c Mice.
Maspi N; Ghaffarifar F; Sharifi Z; Dalimi A; Dayer MS
Arch Immunol Ther Exp (Warsz); 2018 Feb; 66(1):55-64. PubMed ID: 28779346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
